Patients may have questions when they pick up their prescription of Fiasp®. Here are some things you may want to discuss with them.
Talking to adult patients about their Fiasp® prescription
What is Fiasp®?
Fiasp® is a rapid-acting human insulin analog indicated to improve glycemic control in adults with diabetes mellitus.
Dose timing: Fiasp® vs NovoLog® (insulin aspart injection) 100 U/mL1,3
See how dosing options can help patients at mealtime
Fiasp® Trade Unit Product Information
Fiasp® and NovoLog® have the same generic, insulin aspart 100 U/mL, so be sure to confirm the brand name if it isn’t specified on the written script or in the ePrescribing system.